| American Journal of Immunology | |
| The Role of Treg Cells in the Cancer Immunological Response | Science Publications | |
| Zhi-Zhang Yang1  Stephen M. Ansell1  | |
| 关键词: CD4+CD25+; Treg cells; Foxp3; cancer; tumor immunity; immune response; | |
| DOI : 10.3844/ajisp.2009.17.28 | |
| 学科分类:过敏症与临床免疫学 | |
| 来源: Science Publications | |
PDF
|
|
【 摘 要 】
Problem statement: T cell-mediated immunosuppression has been observed for decades without clarification as to which factor was responsible for this observation. The identification of CD4+CD25+ regulatory T (Treg) cells represents a milestone in the filed of immunology and provides an explanation for T-cell-mediated immunosuppression. Although Treg cells were originally identified for their ability to prevent organ-specific autoimmune disease in mice, emerging evidence suggests that Treg cells play a pivotal role in tumor immunity and contribute to tumor growth and progression, thereby having an important impact on the outcome of cancer patients. Approach: This article reviewed the medical literature to describe how Treg cells affect anti-tumor immunity. Results: Treg cells suppressed anti-tumor immunity by inhibiting the effector functions of tumor-specific T cells and NK cells. Importantly, tumor cells played an active role in recruiting and generating Treg cells and creating a suppressive tumor microenvironment. Strategies to deplete Treg cells or inhibit their function had yielded promising results by enhancing anti-tumor immunity in experimental studies as well as clinical practice. Conclusion: A better understanding of the pathophysiology of Treg cells not only increased our knowledge in a variety of aspects of immunology but also potentially benefited cancer patients.
【 授权许可】
Unknown
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO201912010159854ZK.pdf | 148KB |
PDF